Volume 1Issue 1January 2027
The inaugural issue opens the journal with research across pharmaceutical and biomedical sciences. The cover you see here is the Volume 1, Issue 1 identity; the issue itself will appear on the public record on 1 January 2027.
Publication date 1 January 2027
Issue PDF is not yet available. A download will appear here when the compiled file is deposited.
View issue contentsJournal of Pharmaceutical & Biomedical Sciences
An account of the reporting standard, review process and article mix the journal intends to keep as it opens its first issue.
View articleDepartment of Pharmaceutics, Northern Institute of Medical Sciences; Centre for Nanomedicine, Adriatic University
A comparative preclinical study evaluating formulation stability, cellular uptake and pharmacokinetic behaviour across three resistant tumour models.
View articleDepartment of Clinical Pharmacology, Harbour University Hospital
Model-based analysis of dosing exposure in an intensive care cohort, with covariate testing for renal function and body composition.
View articleDepartment of Immunology, Lakeside School of Medicine; Metabolic Inflammation Laboratory, University of the Rift
Profiles metabolic and cytokine markers in paired samples to test whether early shifts track later clinical response.
View articleInstitute of Translational Therapeutics, University of Piemonte
A structured review of the formulation, toxicology and regulatory steps that separate a promising RNA construct from an approved medicine.
View articleOcular Drug Delivery Group, Atlantic College of Pharmacy
Screens the preclinical literature against prespecified criteria and summarises reported residence time and tolerability endpoints.
View articleBiologics Stability Unit, Nordic Medicines Laboratory
A short screening study of aggregation and potency markers following controlled excursions from recommended storage temperature.
View articleDepartment of Hospital Pharmacy, Iberian University Hospital
Describes presentation, work-up and the decision to revert, with the limitations of a single-patient observation stated plainly.
View articleDepartment of Molecular Medicine, Baltic Technical University; Clinical Genomics Unit, Maghreb University Hospital
Describes a reproducible interpretation pipeline and reports its concordance against curated reference calls.
View articleMedicinal Chemistry, Central European Institute of Science
Argues that formulation papers should deposit protocols at a level that another laboratory can run, not merely describe the intention of the method.
View articleDepartment of Hospital Pharmacy, Rhine Biomedical Centre
A comment on the short communication in this issue, asking for excursion duration and product-specific acceptance criteria to be reported together.
View article
